Single Point Insulin Sensitivity Estimator (SPISE), a novel score to evaluate insulin sensitivity, is predictive in anthropometry specified adults with type 2 diabetes mellitus
Open Access
- 11 September 2026
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 137
Abstract
Purpose: The study was aimed at the assessment of non-insulin-based markers as alternatives to the conventional insulin-based indices in anthropometry specified type 2 Diabetes mellitus. The outcome was targeted towards the utility of such indices in diabetes mellitus and associated metabolic derangements centering around insulin resistance. Methods: Fasting venous blood samples were utilized for biochemical analyses. The parameters included plasma glucose, insulin, lipid profile [triglycerides, HDL cholesterol, total cholesterol and LDL cholesterol (Friedewald equation)]. Uric acid, liver enzymes, renal profile, electrolytes, and thyroid function tests were also evaluated. Appropriate statistical analysis, as deemed fit for normal and skewed data were undertaken. Results: Across the BMI categories, significant differences were observed in several insulin-resistance indices. Quantitative Insulin Sensitivity Check Index (QUICKI) values were lowest in the obese group and highest in the normal-weight group ( p < 0.0001). Single Point Insulin Sensitivity Estimator (SPISE) values also showed reduction across normal, overweight, and obese groups ( p < 0.0001). The TyG index demonstrated a significant increase with rising BMI ( p = 0.0002). With reference to utility of SPISE as a predictor in anthropometry specified groups, it demonstrated a near-perfect discriminatory performance with an AUC of 0.99 (95% CI: 0.97–1.00, p < 0.0001). A cut-off value of < 5.55 yielded a sensitivity of 92.5% and specificity of 93.3%. Conclusions: SPISE, independent of insulin, showed high discrimination of BMI-defined obesity in this T2DM cohort, although its performance should be interpreted cautiously because BMI is incorporated into the SPISE equation.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center ExperienceJournal of Clinical and Experimental Hepatology, 2022
- The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up studyJournal of Endocrinological Investigation, 2021
- Validity assessment of the Single-Point Insulin Sensitivity Estimator (SPISE) for diagnosis of cardiometabolic risk in male and female Hispanic post-pubertal adolescents.Scientific Reports, 2020
- SPISE and other fasting indexes of insulin resistance: risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspectsUpsala Journal of Medical Sciences, 2019
- Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide studyJournal of Diabetes Investigation, 2018
- Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolismThe Journal of Physiological Sciences, 2017
- Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional studyThe Lancet Diabetes & Endocrinology, 2017
- Type 2 diabetes mellitusNature Reviews Disease Primers, 2015
- Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesCardiovascular Diabetology, 2011
- The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy SubjectsMetabolic Syndrome and Related Disorders, 2008